INVICTUS is a Phase 3 randomized, double-blind, placebo-controlled, international, multicenter clinical study evaluating the safety, tolerability, and efficacy of QINLOCK compared to placebo in ...
- Data Featured at the ESMO World Congress on Gastrointestinal Cancer 2020 Virtual Meeting - “The data presented today further reinforce the potential of QINLOCK to provide meaningful clinical benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results